NR
Nityananda Reddy Kambam
About Nityananda Reddy Kambam
Data last updated:
Nityananda Reddy Kambam has 33 years in corporate governance. Holds Managing Director and Individual Subscriber roles. Currently with 12 companies, including Aurobindo Pharma Ltd and Engenra Biologics Private Limited. Formerly with 11 companies, such as Curateq Biologics Private Limited and Auro Peptides Limited. Engaged in General Business, Healthcare and more. The 8 current companies with reported revenue have a combined latest revenue of ₹45,630 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurobindo Pharma Ltd L24239TG1986PLC015190 | Managing Director | 30 Dec 1992 | 1986 | ₹34,145 Cr (FY 2026) | Active |
| Apitoria Pharma Private Limited U24298TG2017PTC121342 | Director | 09 Feb 2023 | 2017 | ₹6,812 Cr (FY 2025) | Active |
| Apl Healthcare Limited U24239TG2006PLC052053 | Director | 19 Dec 2006 | 2006 | ₹4,413 Cr (FY 2025) | Active |
| Raidurgam Developers Limited U45100TG2012PLC081892 | Director | 10 Jul 2012 | 2012 | ₹190 Cr (FY 2025) | Active |
| Aurobindo Pharma Foundation U85200TG2020NPL141954 | Director | 20 Jul 2020 | 2020 | ₹50.45 Cr (FY 2025) | Active |
 Pattancheru Enviro-Tech Limited U29219TG1989PLC009683 | Director | 26 Sep 2001 | 1989 | ₹19.79 Cr (FY 2025) | Active |
| Lyfius Pharma Private Limited U24299AP2020PTC116443 | Director | 01 Dec 2023 | 2020 | ₹2 Lakh (FY 2023) | Active |
| Qule Pharma Private Limited U24304AP2020PTC116442 | Director | 01 Dec 2023 | 2020 | ₹50,000 (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Curateq Biologics Private Limited U24110TG2020PTC140190 | Additional Director | 02 May 2020 | 2020 | ₹9.49 Cr (FY 2025) | Active |
| Auro Peptides Limited U24232TG2012PLC078350 | Director | 02 Jan 2012 | 2012 | ₹23.52 Cr (FY 2025) | Active |
| Curepro Parenterals Limited U24232TG2013PLC087101 | Director | 19 Apr 2013 | 2013 | – | Amalgamated |
 Pharmaceuticals Export Promotion Council Of India U24239TG2004NPL043058 | Director | 13 Apr 2004 | 2004 | ₹35.95 Cr (FY 2024) | Active |
| Auronext Pharma Private Limited U74999TG2009PTC109591 | Director | 30 Jul 2010 | 2009 | ₹75.8 Lakh (FY 2023) | Amalgamated |
| Senor Organics Pvt Ltd U24110TG1993PTC016703 | Director | 30 Nov 2006 | 1993 | – | Amalgamated |
| Apl Research Centre Limited U24116TG2006PLC051171 | Director | 15 Sep 2006 | 2006 | – | Amalgamated |
| Hyacinths Pharma Private Limited U24232TG2010PTC069638 | Director | 16 Sep 2013 | 2010 | – | Amalgamated |
| Aurozymes Limited U24232TG2013PLC091383 | Director | 28 Nov 2013 | 2013 | – | Amalgamated |
 Trident Life Sciences Limited U24239TG2004PLC044102 | Additional Director | 18 Sep 2009 | 2004 | – | Amalgamated |
 Silicon Life Sciences Private Limited U85100TG2008PTC057669 | Director | 30 Aug 2013 | 2008 | ₹139 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nityananda Reddy Kambam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nityananda Reddy Kambam
Nityananda Reddy Kambam has 33 years in corporate governance. Holds Managing Director and Individual Subscriber roles. Currently with 12 companies, including Aurobindo Pharma Ltd and Engenra Biologics Private Limited. Formerly with 11 companies, such as Curateq Biologics Private Limited and Auro Peptides Limited. Engaged in General Business, Healthcare and more. The 8 current companies with reported revenue have a combined latest revenue of ₹45,630 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026).
Nityananda Reddy Kambam is associated with 12 companies as Managing Director and Individual Subscriber, including Aurobindo Pharma Ltd (₹34,145 Cr), Apitoria Pharma Private Limited (₹6,812 Cr), Apl Healthcare Limited (₹4,413 Cr).
Nityananda Reddy Kambam has expertise in General Business, Healthcare and other sectors.
Nityananda Reddy Kambam has 33 years in corporate governance.
By reported revenue, the largest current company of Nityananda Reddy Kambam is Aurobindo Pharma Ltd, with revenue of ₹34,145 Cr (FY 2026).
The 8 current companies of Nityananda Reddy Kambam that report revenue have a combined latest revenue of ₹45,630 Cr.
Nityananda Reddy Kambam currently holds positions at 12 companies; the 5 largest by reported revenue are Aurobindo Pharma Ltd (₹34,145 Cr), Apitoria Pharma Private Limited (₹6,812 Cr), Apl Healthcare Limited (₹4,413 Cr), Raidurgam Developers Limited (₹190 Cr), Aurobindo Pharma Foundation (₹50.45 Cr).